Lifshitz Law PLLC Announces Investigations of SGEN, PRVB, KBAL, and ADAP

Error message

Notice: Undefined property: stdClass::$ds_changed in eval() (line 16 of /var/www/7/modules/php/php.module(80) : eval()'d code).
Notice: Undefined property: stdClass::$ss_search_api_url in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).
Notice: Undefined property: stdClass::$tm_title in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).

Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of SGEN to Pfizer Inc. for $229.00 per share in cash.

Metadata

Provider:

GlobeNewswire, Inc.

Retrieved on:

Sunday, March 19, 2023

Information

Tags:

Therapy, ADAP, HNI, Telephone, PLLC, Pfizer, Sale, Advertising, HNI Corporation, KBAL, Hewlett, Online shopping

Geotags:

HEWLETT, NY, US, KIMBALL

⚠ partially generated by AI ↴

Organisation:

LIFSHITZ LAW FIRM, LIFSHITZ LAW FIRM, P.C., SEAGEN, PROVENTION BIO, KIMBALL INTERNATIONAL

Stock Symbol:

Summary

Key Points:

Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of SGEN to Pfizer Inc. for $229.00 per share in cash.
Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of PRVB to Sanofi S.A. for $25.00 per share in cash.
Lifshitz L aw PLLC announces investigation into possible breach of fiduciary duties in connection with the merger of ADAP and TCR² Therapeutics, Inc.
The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516)493-9780.

NEW YORK, March 18, 2023 (GLOBE NEWSWIRE) --

Seagen Inc. (NASDAQ: SGEN)

Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of SGEN to Pfizer Inc. for $229.00 per share in cash.

If you are a SGEN investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Provention Bio, Inc. (NASDAQ: PRVB)

Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of PRVB to Sanofi S.A. for $25.00 per share in cash.

If you are an PRVB investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Kimball International, Inc. (NASDAQ: KBAL)

Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of KBAL to HNI Corporation for $9.00 in cash and 0.3101 of HNI common stock for each share of Kimball common stock.

If you are an KBAL investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Adaptimmune Therapeutics PLC (NASDAQ: ADAP)

Lifshitz Law PLLC announces investigation into possible breach of fiduciary duties in connection with the merger of ADAP and TCR² Therapeutics, Inc. Following the merger, pre-merger Adaptimmune shareholders are expected to own approximately 75.0% of the outstanding equity of the combined company.

If you are an ADAP investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

ATTORNEY ADVERTISING.© 2023 Lifshitz Law PLLC. The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.
Lifshitz Law PLLC
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: [email protected]